Reported Standalone quarterly numbers for Panacea Biotec are:
Net Sales at Rs 90.81 crore in September 2025 up 18.49% from Rs. 76.64 crore in September 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 15.64 crore in September 2025 down 1312.4% from Rs. 1.29 crore in September 2024.
EBITDA stands negative at Rs. 10.09 crore in September 2025 down 199.41% from Rs. 10.15 crore in September 2024.
Panacea Biotec shares closed at 345.15 on November 20, 2025 (NSE) and has given -32.00% returns over the last 6 months and -16.63% over the last 12 months.
Story continues below Advertisement
| Panacea Biotec | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'25 | Jun'25 | Sep'24 | | Net Sales/Income from operations | 90.81 | 112.25 | 76.64 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 90.81 | 112.25 | 76.64 | | EXPENDITURE | | Consumption of Raw Materials | 26.88 | 60.94 | 22.04 | | Purchase of Traded Goods | 0.78 | 1.14 | -- | | Increase/Decrease in Stocks | 17.74 | 0.06 | -4.33 | | Power & Fuel | -- | -- | -- | | Employees Cost | 27.04 | 25.37 | 24.45 | | Depreciation | 4.91 | 4.77 | 5.09 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 32.07 | 27.76 | 27.74 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -18.61 | -7.79 | 1.65 | | Other Income | 3.61 | 4.95 | 3.41 | | P/L Before Int., Excpt. Items & Tax | -15.00 | -2.84 | 5.06 | | Interest | 5.93 | 6.00 | 3.76 | | P/L Before Exceptional Items & Tax | -20.93 | -8.84 | 1.30 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -20.93 | -8.84 | 1.30 | | Tax | -5.29 | -2.14 | 0.01 | | P/L After Tax from Ordinary Activities | -15.64 | -6.70 | 1.29 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -15.64 | -6.70 | 1.29 | | Equity Share Capital | 6.13 | 6.13 | 6.13 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.55 | -1.09 | 0.21 | | Diluted EPS | -2.55 | -1.09 | 0.21 | | EPS After Extra Ordinary | | Basic EPS | -2.55 | -1.09 | 0.21 | | Diluted EPS | -2.55 | -1.09 | 0.21 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
